AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Business Of Biotech
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.
May 27, 2024
Dr. Brian Fiske of Mythic Therapeutics shares his journey transitioning from academia to biotech industry. They discuss developing ADCs for lung cancer, challenges in funding, and strategic planning. The podcast explores Mythic's unique approach in the ADC space and navigating the competitive biotech industry.
56:38
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Dr. Brian Fiske's diverse background in science and business fuels Mythic Therapeutics' innovative approach to antibody drug conjugates.
- Transitioning seamlessly from academia to industry, Dr. Fiske's entrepreneurial vision propels Mythic Therapeutics' phase one study for non-small cell lung cancer.
Deep dives
Dr. Brian Fisk's Academic and Industrial Overlap
Dr. Brian Fisk seamlessly transitioned from academia to industry with his expertise in cancer metabolism, directly impacting the development and commercialization of two drugs. Focused on antibody drug conjugates, his entrepreneurial decisions are driving Metzik Therapeutics' phase one study for non-small cell lung cancer.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode